Literature DB >> 23857427

Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.

Ana Ruiz1, Sara Lemoinne, Fabrice Carrat, Christophe Corpechot, Olivier Chazouillères, Lionel Arrivé.   

Abstract

UNLABELLED: Magnetic resonance imaging (MRI) with magnetic resonance cholangiography (MRC) has become the radiologic standard of reference for diagnosis of primary sclerosing cholangitis (PSC). However, natural history of radiologic features of PSC is poorly known. In the current study, we aimed at analyzing the course of PSC using three-dimensional (3D) MRC and liver MRI to find predictive radiologic features of progression. PSC patients, followed up in our center, with at least two 3D MRCs performed in at least a 1-year interval, were retrospectively reviewed. We built an interpretation standard model to score precisely bile ducts and liver parenchyma features. The primary endpoint was overall radiologic course, including worsening, improvement, or stabilization. Radiologic features were analyzed by logistic regression. We reviewed 289 MRIs from 64 patients upon a mean radiologic follow-up of 4 years (range, 1-9). Radiologic features worsened in 37 patients (58%) and stabilized in 27 (42%); no patient showed improvement. Multivariate analysis resulted in two MRI progression risk scores, based on the combination of predictive radiologic features (score without gadolinium administration = 1 × dilatation of intrahepatic bile ducts + 2 × dysmorphy + 1 × portal hypertension; score with gadolinium administration = 1 × dysmorphy + 1 × parenchymal enhancement heterogeneity). These scores were associated with radiologic progression, with an area under the curve of 80 and 83% ± 4%.
CONCLUSION: A majority of PSC patients develop radiologic aggravation upon MRI over 4 years. Two simple scores can predict radiologic progression.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857427     DOI: 10.1002/hep.26620

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Primary sclerosing cholangitis in the setting of normal liver chemistries can be associated with severe ductal disease and dominant strictures.

Authors:  Thomas Queen; Kristen Cox; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2014-01       Impact factor: 3.199

2.  MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.

Authors:  Candice A Bookwalter; Sudhakar K Venkatesh; John E Eaton; Thomas D Smyrk; Richard L Ehman
Journal:  Abdom Radiol (NY)       Date:  2018-12

Review 3.  The evolution of natural history of primary sclerosing cholangitis.

Authors:  Will R Takakura; James H Tabibian; Christopher L Bowlus
Journal:  Curr Opin Gastroenterol       Date:  2017-03       Impact factor: 3.287

4.  Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.

Authors:  Laetitia Nguyen; Nora Cazzagon; Christophe Corpechot; Sanaâ El Mouhadi; Sara Lemoinne; Olivier Chazouillères; Lionel Arrivé
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

5.  Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging.

Authors:  Sehnaz Evrimler; Jordan K Swensson; Vijay S Are; Temel Tirkes; Raj Vuppalanchi; Fatih Akisik
Journal:  Abdom Radiol (NY)       Date:  2020-11-01

Review 6.  Primary sclerosing cholangitis: review for radiologists.

Authors:  Matthew A Morgan; Rachita Khot; Karthik M Sundaram; Daniel R Ludwig; Rashmi T Nair; Pardeep K Mittal; Dhakshina M Ganeshan; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-09-05

Review 7.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

8.  Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Authors:  Nahla Azzam; Yazed AlRuthia; Othman Alharbi; Abdulrahman Aljebreen; Majid Almadi; Edward V Loftus
Journal:  Hepatol Int       Date:  2020-12-28       Impact factor: 6.047

9.  Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography.

Authors:  Rolf Reiter; Mehrgan Shahryari; Heiko Tzschätzsch; Dieter Klatt; Britta Siegmund; Bernd Hamm; Jürgen Braun; Ingolf Sack; Patrick Asbach
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

10.  Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.

Authors:  Sudhakar K Venkatesh; Christopher L Welle; Frank H Miller; Kartik Jhaveri; Kristina I Ringe; John E Eaton; Helen Bungay; Lionel Arrivé; Ahmed Ba-Ssalamah; Aristeidis Grigoriadis; Christoph Schramm; Ann S Fulcher
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.